Fecal Microbiota Transplantation (FMT)

Seema Nair Parvathy (PhD), Research Coordinator with Lawson Health Research Institute, holds up fecal transplant capsules being used at St. Joseph’s Health Care London to treat patients with C. difficile and to study their potential use for many other health conditions.

A Breakthrough in Cancer Care Starts with You

St. Joseph’s has pioneered Fecal Microbiota Transplantation (FMT) using a revolutionary capsule treatment. This non-invasive therapy transfers healthy bacteria from carefully screened donors into patients and boasts an impressive 97% success rate in treating Clostridioides difficile (C.difficile) infections.

Now, this life-saving treatment is showing incredible promise in cancer care. In a groundbreaking clinical trial, researchers at Lawson Health Research Institute discovered that FMT enhances the response to immunotherapy for patients with advanced melanoma. St. Joseph’s is not only participating in this national trial but also leading capsule production for 23 cancer centers across Canada.

Why Your Support Matters

Your donation will directly fund:

  • Life-saving capsule production for clinical trials.
  • Skilled personnel who carry out critical research.
  • Screening and quality control to ensure patient safety.

By giving today, you are advancing care for patients facing a devastating diagnosis and helping bring innovative treatments to those who need them most. Your generosity can change lives. Together, we can advance life-saving research and bring hope to cancer patients across Canada.

Donate today